Cystic Fibrosis and Osteoporosis
A result of the development of important research and treatment of patients who suffer from Cystic Fibrosis (Cystic Fibrosis) many are living longer with the change in mean survival of 5 years in s1950 to 30 years in the present day, although some may live longer. Hopkins is the largest in the age of 65 years. However, with the permanence of life, what happened was not expected, Kda osteoporosis or osteoporosis Austiubirosis ((Osteoporosis. Although this disease often Izamil age, but it also affects young patients and lead to pain and rib fractures or Nkhaaip Fork in turn disrupt the natural treatment for the degradation of mucus in the lungs, which is one of the prominent symptoms of this situation.
One of the reasons for the weakness of the bone chip and premature due to the fact that patients with cystic fibrosis have difficulty absorbing vitamin "d" which is the basis for building bone. Another reason lies in the real estate used for the treatment of cystic fibrosis: Jlecoqorticidz (glococorticoids) where nearly all those on this therapy suffer from accelerated bone chip prematurely.
For this reason, the lung doctor, Michael Boyle ((pulmonologist Michael Boyle of the Center for Medical Research at Hopkins fibrosis Fibrosis (Cystic Fibrosis Clinical Research Center) to target this problem in young patients in the hope of improving treatment reduces the risk of osteoporosis and break it. Boyle is the measurement of the impact of high doses vitamin "d" in the young patients. with the recommendation that the model in this case is the addition of two doses a week for two months, however, Powell found that the impact of this addendum is little to increase the stock of vitamin "d". Boyle is now giving higher doses for effective simultaneous with the carrying capacity. and taught at the same time called Besfosfonayats drugs (bisphosphonates) to prevent the bone chip. work closely with pediatric pneumonia in the Hopkins Boyle is optimistic to find a treatment to delay or to prevent the bone chip. imperative that young patients have to live with the possibility of a death is documented pay for access to the answers to this dilemma.
One of the reasons for the weakness of the bone chip and premature due to the fact that patients with cystic fibrosis have difficulty absorbing vitamin "d" which is the basis for building bone. Another reason lies in the real estate used for the treatment of cystic fibrosis: Jlecoqorticidz (glococorticoids) where nearly all those on this therapy suffer from accelerated bone chip prematurely.
For this reason, the lung doctor, Michael Boyle ((pulmonologist Michael Boyle of the Center for Medical Research at Hopkins fibrosis Fibrosis (Cystic Fibrosis Clinical Research Center) to target this problem in young patients in the hope of improving treatment reduces the risk of osteoporosis and break it. Boyle is the measurement of the impact of high doses vitamin "d" in the young patients. with the recommendation that the model in this case is the addition of two doses a week for two months, however, Powell found that the impact of this addendum is little to increase the stock of vitamin "d". Boyle is now giving higher doses for effective simultaneous with the carrying capacity. and taught at the same time called Besfosfonayats drugs (bisphosphonates) to prevent the bone chip. work closely with pediatric pneumonia in the Hopkins Boyle is optimistic to find a treatment to delay or to prevent the bone chip. imperative that young patients have to live with the possibility of a death is documented pay for access to the answers to this dilemma.
